Akemi Katsurada Selected Research

Angiotensinogen

1/2020	Blockade of sodium-glucose cotransporter 2 suppresses high glucose-induced angiotensinogen augmentation in renal proximal tubular cells.
1/2019	Advanced Glycation End Products Stimulate Angiotensinogen Production in Renal Proximal Tubular Cells.
1/2019	Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus.
5/2016	6β-Hydroxytestosterone, a Cytochrome P450 1B1-Testosterone-Metabolite, Mediates Angiotensin II-Induced Renal Dysfunction in Male Mice.
1/2016	Increased angiotensinogen expression, urinary angiotensinogen excretion, and tissue injury in nonclipped kidneys of two-kidney, one-clip hypertensive rats.
10/2014	Renoprotective effects of direct renin inhibition in glomerulonephritis.
10/2010	Tumor necrosis factor-{alpha} suppresses angiotensinogen expression through formation of a p50/p50 homodimer in human renal proximal tubular cells.
4/2010	Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy.
2/2009	Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.
9/2008	Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akemi Katsurada Research Topics

Disease

11	Hypertension (High Blood Pressure) 01/2020 - 05/2008
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 08/2008
3	Body Weight (Weight, Body) 01/2016 - 09/2008
3	IGA Glomerulonephritis (IGA Nephropathy) 08/2009 - 06/2007
2	Diabetes Mellitus 01/2020 - 01/2019
2	Hyperglycemia 01/2020 - 01/2019
2	Proteinuria 01/2017 - 05/2016
2	Kidney Diseases (Kidney Disease) 10/2014 - 05/2008
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Renal Hypertension 01/2017
1	Inflammation (Inflammations) 05/2016
1	Fibrosis (Cirrhosis) 05/2016
1	Glomerulonephritis 10/2014
1	Hypertrophy 04/2010
1	Weight Loss (Weight Reduction) 04/2010
1	Obesity 04/2010
1	Chronic Renal Insufficiency 09/2008
1	Nephritis 05/2008

Drug/Important Bio-Agent (IBA)

13	AngiotensinogenIBA 01/2020 - 06/2007
5	Angiotensin IIIBA 01/2020 - 02/2009
4	SodiumIBA 05/2016 - 09/2008
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2010
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2016 - 02/2009
3	ReninIBA 10/2014 - 09/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2009 - 08/2008
3	Immunoglobulin A (IgA)IBA 08/2009 - 05/2008
2	Messenger RNA (mRNA)IBA 01/2019 - 10/2014
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2017 - 05/2016
2	Type 1 Angiotensin ReceptorIBA 05/2016 - 01/2016
2	CreatinineIBA 02/2009 - 09/2008
1	Advanced Glycation End ProductsIBA 01/2019
1	8-epi-prostaglandin F2alphaIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	CanagliflozinIBA 01/2019
1	GTP-Binding Proteins (G-Protein)IBA 01/2017
1	2-MethoxyestradiolIBA 01/2017
1	Estrogen Receptor alphaIBA 01/2017
1	Testosterone (Sustanon)FDA Link 05/2016
1	Plasminogen Activators (Plasminogen Activator)IBA 10/2014
1	aliskiren FDA Link 10/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2010
1	EnzymesIBA 04/2010
1	ImmunosorbentsIBA 04/2010
1	AngiotensinsIBA 02/2009
1	PotassiumIBA 09/2008
1	Biomarkers (Surrogate Marker)IBA 09/2008

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2016
1	Denervation 12/2016
1	Castration 05/2016